Related Experiment Video
Updated: Oct 20, 2025

A Tablet-Based Curriculum-Based Measurement Protocol for Kindergarten Writing
Published on: February 7, 2025
External Validation of the SYNTAX Score II 2020
Hironori Hara1, Hiroki Shiomi2, David van Klaveren3
1Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Insights
The SYNTAX score II 2020 accurately predicts 5-year mortality after coronary revascularization in patients with complex coronary artery disease. It helps guide decisions between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Surgery
Background:
- The SYNTAX score II 2020 (SSII-2020) is a validated tool for predicting outcomes after revascularization.
- It assesses risks for death and major adverse cardiac and cerebrovascular events (MACE) following PCI and CABG in patients with 3-vessel disease (3VD) and/or left main coronary artery disease (LMCAD).
Purpose of the Study:
- To evaluate the SSII-2020's effectiveness in determining the optimal revascularization strategy (PCI vs. CABG) in a real-world, non-randomized setting.
- To assess the score's ability to predict long-term mortality and MACE in a large patient cohort.
Main Methods:
- Analysis of 7,362 patients with 3VD and/or LMCAD from a Japanese PCI/CABG registry.
- Assessment of 5-year mortality and MACE using the SSII-2020.
- Statistical evaluation included Harrell's C statistic for discrimination and calibration plots for agreement between predicted and observed outcomes.
Main Results:
- The SSII-2020 demonstrated good predictive accuracy for 5-year mortality post-PCI and CABG (C-index = 0.72).
- Patients stratified by predicted mortality risk showed no significant difference in observed mortality between PCI and CABG for lower risk (<4.5%), but CABG was superior for higher risk (≥4.5%).
- The SSII-2020's accuracy in recommending treatment for MACE was insufficient.
Conclusions:
- The SSII-2020 shows potential as a decision-making tool for revascularization strategies in patients with 3VD and/or LMCAD, particularly for predicting mortality.
- Further refinement may be needed for its application in guiding treatment decisions for MACE.
Background:
The SYNTAX score II 2020 (SSII-2020) was derived from cross correlation and externally validated in randomized trials to predict death and major adverse cardiac and cerebrovascular events (MACE) following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with 3-vessel disease (3VD) and/or left main coronary artery disease (LMCAD).
Objectives:
The authors aimed to investigate the SSII-2020's value in identifying the safest modality of revascularization in a non-randomized setting.
Methods:
Five-year mortality and MACE were assessed in 7,362 patients with 3VD and/or LMCAD enrolled in a Japanese PCI/CABG registry. The discriminative abilities of the SSII-2020 were assessed using Harrell's C statistic. Agreement between observed and predicted event rates following PCI or CABG and treatment benefit (absolute risk difference [ARD]) for these outcomes were assessed by calibration plots.
Results:
The SSII-2020 for 5-year mortality well predicted the prognosis after PCI and CABG (C-index = 0.72, intercept = -0.11, slope = 0.92). When patients were grouped according to the predicted 5-year mortality ARD, <4.5% (equipoise of PCI and CABG) and ≥4.5% (CABG better), the observed mortality rates after PCI and CABG were not significantly different in patients with lower predicted ARD (observed ARD: 2.1% [95% CI: -0.4% to 4.4%]), and the significant difference in survival in favor of CABG was observed in patients with higher predicted ARD (observed ARD: 9.7% [95% CI: 6.1%-13.3%]). For MACE, the SSII-2020 could not recommend a specific treatment with sufficient accuracy.
Conclusions:
The SSII-2020 for predicting 5-year death has the potential to support decision making on revascularization in patients with 3VD and/or LMCAD.
More Related Videos
09:00Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
Published on: August 16, 2024
09:16Use of a Video Scoring Anchor for Rapid Serial Assessment of Social Communication in Toddlers
Published on: March 14, 2018
Related Concept Videos
The Anderson-Darling Test
Reliability and Validity
Confidence Coefficient
Kendall's Coefficient of Concordance
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Routh-Hurwitz Criterion II
The first scenario occurs when a singular zero appears in the first column of the Routh table. This situation creates a division by zero issues. To resolve this, a small positive or negative number, denoted as epsilon (∈), is substituted for the zero. The stability analysis proceeds by assuming a sign for ∈. If ∈ is positive, any sign change in the first...